510(k) K791231

DAC-CEL T4 by Burroughs Wellcome Co. — Product Code CDX

K791231 is an FDA 510(k) premarket notification submitted by Burroughs Wellcome Co. for the device "DAC-CEL T4". The FDA issued a decision of Substantially Equivalent on September 4, 1979. The device falls under product code CDX (Radioimmunoassay, Total Thyroxine), a Class II device regulated under 21 CFR 862.1700. Burroughs Wellcome Co. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 4, 1979
Date Received
July 2, 1979
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Radioimmunoassay, Total Thyroxine
Device Class
Class II
Regulation Number
862.1700
Review Panel
CH
Submission Type